Hile BioPharma
- Headquarters
- Shanghai
- Business Model
- B2B
About
Hile BioPharma (stock ticker 603718.SS) is a leading animal vaccine manufacturer based in Shanghai, China, specializing in the sales, marketing, and commercialization of veterinary biological products. The company focuses on bringing animal health vaccines to the Chinese market, operating in a highly regulated sector with deep expertise in commercializing livestock and companion animal biologics. F-Prime Capital made an initial investment in Hile in 2010, reflecting early recognition of China's growing animal health market.
Summary
Hile BioPharma is a Biotech company based in Shanghai, China.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...